...
首页> 外文期刊>Cutis >Melkersson-Rosenthal Syndrome Successfully Treated With Adalimumab
【24h】

Melkersson-Rosenthal Syndrome Successfully Treated With Adalimumab

机译:Melkersson-rosenthal综合征成功用Adalimumab治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Melkersson-Rosenthal syndrome (MRS) is a rare syndrome of facial nerve palsy, facial edema, and lingua plicata that can be difficult to treat. We observed a patient with MRS of 4 years' duration that was unsuccessfully treated with multiple therapies. After a variety of diagnoses were considered at outside institutions, including Bell palsy, we diagnosed the patient with MRS based on clinical presentation of the classic triad. Treatment with adalimumab, a tumor necrosis factor alpha (TNF-alpha) antibody, showed improvement and relapse-free progress. Further research is needed regarding the role of TNF-alpha inhibitors in managing this rare condition.
机译:Melkersson-rosenthal综合征(MRS)是一种罕见的面神经麻痹,面部水肿和语气综合征,可能难以治疗。 我们观察了患有4年持续时间的患者,这些持续时间不成功地用多种疗法治疗。 在外部诊断局部诊断,包括贝尔麻痹,基于经典三合会的临床介绍,我们将患有MRS的患者。 用Adalimalab治疗,肿瘤坏死因子α(TNF-α)抗体,显示出改善和无复发进展。 关于TNF-α抑制剂在管理这种罕见病症方面的作用,需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号